Let’s look at a competitor, 4DX from last year’s performance (which overall was heading in the right direction)
- $1.2 million revenue.
- $2.1m in others income.
- $21.97 million operating costs (loss).
Market Cap - $319m
As such I’m confused by your statement re: SHG are you genuinely asking or trying to indicate that it’s overvalued? There are hundreds of small caps that don’t even come close to justifying their MC.
The social media love child, Imagion Biosystems (IBX) has an MC of $160m...where is the revenue? It’s about sentiment and potential. I like IBX long term for what it’s worth.
- Forums
- ASX - By Stock
- Ann: Reinstatement to Official Quotation
Let’s look at a competitor, 4DX from last year’s performance...
Featured News
Add SHG (ASX) to my watchlist
|
|||||
Last
9.9¢ |
Change
0.001(1.02%) |
Mkt cap ! $19.36M |
Open | High | Low | Value | Volume |
9.7¢ | 9.9¢ | 9.7¢ | $28.29K | 288.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 9.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 73615 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 15000 | 0.094 |
1 | 26881 | 0.093 |
2 | 93739 | 0.092 |
2 | 116890 | 0.091 |
4 | 224268 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 73615 | 1 |
0.100 | 38390 | 1 |
0.105 | 35000 | 1 |
0.110 | 261153 | 4 |
0.115 | 50000 | 1 |
Last trade - 16.10pm 24/07/2024 (20 minute delay) ? |
Featured News
SHG (ASX) Chart |
The Watchlist
LGP
LITTLE GREEN PHARMA LTD
Paul Long, CEO
Paul Long
CEO
Previous Video
Next Video
SPONSORED BY The Market Online